Cargando…

Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project

PURPOSE: Dosimetry is rarely performed for the treatment of differentiated thyroid cancer patients with Na[(131)I]I (radioiodine), and information regarding absorbed doses delivered is limited. Collection of dosimetry data in a multi-centre setting requires standardised quantitative imaging and dosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taprogge, Jan, Vergara-Gil, Alex, Leek, Francesca, Abreu, Carla, Vávrová, Lenka, Carnegie-Peake, Lily, Schumann, Sarah, Eberlein, Uta, Lassmann, Michael, Schurrat, Tino, Luster, Markus, Verburg, Frederik A., Vallot, Delphine, Vija, Lavinia, Courbon, Frédéric, Newbold, Kate, Bardiès, Manuel, Flux, Glenn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256579/ https://www.ncbi.nlm.nih.gov/pubmed/37300572 http://dx.doi.org/10.1007/s00259-023-06295-0

Ejemplares similares

Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project
por: Taprogge, Jan, et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease
por: Taprogge, Jan, et al.
Publicado: (2021)

Quantification and dosimetry of small volumes including associated uncertainty estimation
por: Carnegie-Peake, Lily, et al.
Publicado: (2022)

The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
por: Taprogge, Jan, et al.
Publicado: (2023)

Recommendations for Multicentre Clinical Trials Involving Dosimetry for Molecular Radiotherapy
por: Taprogge, J., et al.
Publicado: (2021)

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review
por: Eberlein, Uta, et al.
Publicado: (2011)

Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
por: Eilsberger, Friederike, et al.
Publicado: (2020)

Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
por: Verburg, Frederik A., et al.
Publicado: (2019)

From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
por: Flux, G. D., et al.
Publicado: (2017)

Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy
por: Wadsley, Jon, et al.
Publicado: (2023)

GATE/Geant4-based dosimetry for ex vivo in solution irradiation of blood with radionuclides
por: Salas-Ramirez, Maikol, et al.
Publicado: (2022)

Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat
por: van Velsen, Evert F S, et al.
Publicado: (2023)

Characterisation of the attenuation properties of 3D-printed tungsten for use in gamma camera collimation
por: Gear, Jonathan I., et al.
Publicado: (2019)

Multi-modal quantification of pathway activity with MAYA
por: Landais, Yuna, et al.
Publicado: (2023)

EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for (131)I mIBG treatment of neuroendocrine tumours
por: Gear, Jonathan, et al.
Publicado: (2020)

Super-horizon scale dynamics of multi-field inflation
por: Sasaki, M
Publicado: (1998)

Uncertainty quantification of bioassay functions for the internal dosimetry of radioiodine
por: Kwon, Tae-Eun, et al.
Publicado: (2020)

Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer: Protocol for a European Multicenter Prospective Cohort Study (MEDIRAD EARLY HEART Study)
por: Walker, Valentin, et al.
Publicado: (2018)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Multi-Horizon Air Pollution Forecasting with Deep Neural Networks
por: Arsov, Mirche, et al.
Publicado: (2021)

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
por: Pacilio, Massimiliano, et al.
Publicado: (2022)

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives
por: Verburg, Frederik A., et al.
Publicado: (2021)

RadioLigand Therapy with [(177)Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in France
por: Terroir, Marie, et al.
Publicado: (2023)

An Efficient Multi-Path Multitarget Tracking Algorithm for Over-The-Horizon Radar †
por: Huang, Yuan, et al.
Publicado: (2019)

Transformers for Multi-Horizon Forecasting in an Industry 4.0 Use Case
por: Vakaruk, Stanislav, et al.
Publicado: (2023)

Clinical Indications for Treatment with Multi-Kinase Inhibitors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer
por: Fukuda, Naoki, et al.
Publicado: (2021)

Imaging and dosimetry for radium-223: the potential for personalized treatment
por: Flux, Glenn D
Publicado: (2017)

IAU Symposium 179: New Horizons from Multi-Wavelength Sky Surveys
por: Collective
Publicado: (1996)

Forecast horizon of multi-item dynamic lot size model with perishable inventory
por: Jing, Fuying, et al.
Publicado: (2017)

Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study)
por: Locquet, Médéa, et al.
Publicado: (2022)

Oncologic Imaging of the Lymphatic System: Current Perspective with Multi-Modality Imaging and New Horizon
por: Elshikh, Mohamed, et al.
Publicado: (2021)

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [(223)Ra]RaCl(2) and [(224)Ra]RaCl(2)
por: Lassmann, Michael, et al.
Publicado: (2023)

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
por: Pacini, Furio, et al.
Publicado: (2021)

Investigation of the Suitability of a Commercial Radiation Sensor for Pretherapy Dosimetry of Radioiodine Treatment Patients
por: O’Callaghan, Janet, et al.
Publicado: (2022)

EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
por: Sjögreen Gleisner, Katarina, et al.
Publicado: (2022)

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
por: Wirth, Lori J, et al.
Publicado: (2022)

Multi-horizon short-term load forecasting using hybrid of LSTM and modified split convolution
por: Ullah, Irshad, et al.
Publicado: (2023)

False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
por: Barbaro, Daniele, et al.
Publicado: (2023)

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
por: Capdevila, Jaume, et al.
Publicado: (2023)

The effect of modern PET technology and techniques on the EANM paediatric dosage card
por: Dickson, John, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5i7fqd28nu2qhvbcrpv4ldos4s